HIV: reactive oxygen species, enveloped viruses and hyperbaric oxygen
- 1 September 2000
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 55 (3) , 232-238
- https://doi.org/10.1054/mehy.2000.1048
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- HIV antiviral effects of hyperbaric oxygen therapyJournal of the Association of Nurses in AIDS Care, 1996
- The role of oxidative stress in HIV diseaseFree Radical Biology & Medicine, 1995
- Inactivation of Enveloped Viruses in Human Bodily Fluids by Purified LipidsaAnnals of the New York Academy of Sciences, 1994
- Inactivation of Visna Virus and Other Enveloped Viruses by Free Fatty Acids and MonoglyceridesAnnals of the New York Academy of Sciences, 1994
- The cat/feline immunodeficiency virus model for transmucosal transmission of AIDSAIDS, 1993
- The role of reactive oxygen species, antioxidants and phytopharmaceuticals in human immunodeficiency virus activityMedical Hypotheses, 1993
- Merocyanine 540-sensitized photoinactivation of enveloped viruses in blood products: site and mechanism of phototoxicityBlood, 1992
- CPF-DD is an inhibitor of infection by human immunodeficiency virus and other enveloped viruses in vitroVirology, 1992
- Antiviral activity of 1-docosanol, an inhibitor of lipid-enveloped viruses including herpes simplex.Proceedings of the National Academy of Sciences, 1991
- INACTIVATION OF HTLV-III/LAV-INFECTED CULTURES OF NORMAL HUMAN LYMPHOCYTES BY NONOXYNOL-9 IN VITROThe Lancet, 1985